First Manhattan CO Ionis Pharmaceuticals Inc Transaction History

First Manhattan CO

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$34.73 - $43.33 $26,915 - $33,580	-775 Reduced 50.0%	775 $31,000
Q1 2023 May 15, 2023	SELL	$33.58 - $41.2 $14,271 - $17,510	-425 Reduced 21.52%	1,550 $55,000
Q2 2022 Aug 15, 2022	BUY	$31.71 - $43.0 $24,575 - $33,325	775 Added 64.58%	1,975 $73,000
Q2 2021 Aug 16, 2021	SELL	$34.54 - $47.25 $12.9 Million - $17.7 Million	-374,100 Reduced 99.68%	1,200 $47,000
Q1 2021 May 14, 2021	BUY	$42.51 - $63.78 $7.26 Million - $10.9 Million	170,900 Added 83.61%	375,300 $16.9 Million
Q4 2020 Feb 16, 2021	SELL	$45.3 - $60.27 $4,983 - $6,629	-110 Reduced 0.05%	204,400 $11.6 Million
Q3 2020 Nov 12, 2020	BUY	$47.45 - $62.95 $9.64 Million - $12.8 Million	203,260 Added 16260.8%	204,510 $9.7 Million
Q4 2019 Feb 13, 2020	SELL	$53.85 - $65.27 $1,346 - $1,631	-25 Reduced 1.96%	1,250 $75,000
Q2 2019 Aug 16, 2019	BUY	$62.09 - $86.14 $76,060 - $105,521	1,225 Added 2450.0%	1,275 $81,000
Q1 2018 Apr 20, 2018	SELL	$44.08 - $55.05 $49,105 - $61,325	-1,114 Reduced 95.7%	50 $2,000
Q4 2017 Jan 22, 2018	BUY	$50.3 - $64.39 $15,794 - $20,218	314 Added 36.94%	1,164 $58,000
Q3 2017 Oct 25, 2017	BUY	$45.56 - $59.57 $38,726 - $50,634	850	850 $43,000

402

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.